Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:27:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:19:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the site's header and footer, replacing the visible study details and navigation.
    Difference
    19%
    Check dated 2026-09-19T21:50:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page now lists Melanoma as a related topic and adds a MedlinePlus Genetics related topics section to connect the trial to broader cancer resources. This contextual enhancement helps readers navigate to additional background information without changing the trial data.
    Difference
    0.2%
    Check dated 2026-09-05T19:25:53.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.6.6' appeared, and related topics items including 'Melanoma' and 'MedlinePlus Genetics' along with a prior revision tag 'Revision: v3.6.5' were removed. This indicates a minor site maintenance update affecting navigation/metadata rather than the study details.
    Difference
    0.2%
    Check dated 2026-08-29T19:09:43.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now includes Melanoma and MedlinePlus Genetics related topics. This clarifies the disease focus and connects users with melanoma-related resources.
    Difference
    0.2%
    Check dated 2026-08-15T16:00:34.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.